BioAge Labs (BIOA) Assets Average (2024 - 2026)

BioAge Labs has disclosed Assets Average across 3 years of filings, most recently posting $346.3 million for Q1 2026.

• Assets Average for Q1 2026 came in at $346.3 million, down 1.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $346.3 million (down 1.36% YoY), and the FY2025 annual result was $326.6 million, up 70.01% from the prior year.
• Assets Average came in at $346.3 million for Q1 2026 at BioAge Labs, up from $300.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $351.0 million in Q1 2025 to a low of $300.0 million in Q4 2025.
• The 3-year median for Assets Average is $339.6 million (2025), against an average of $332.0 million.
• Across the five-year window, Assets Average retreated 13.75% in 2025 and declined 1.36% in 2026, its largest moves.
• BioAge Labs' Assets Average stood at $347.8 million in 2024, then decreased by 13.75% to $300.0 million in 2025, then climbed by 15.43% to $346.3 million in 2026.
• The last three Assets Average figures came in at $346.3 million (Q1 2026), $300.0 million (Q4 2025), and $313.6 million (Q3 2025), per Business Quant data.